nm.2018-Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
本文檔由 Science 分享于2018-09-02 16:01
暫無簡介
手機或平板掃掃即可繼續訪問
推薦豆丁書房APP 掃掃更高清